Frontlight ResearchEarly access
Trial site
Huanggang Central Hospital
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Stroke2 trials
- Type 2 diabetes2 trials
- Bladder cancer1 trial
- Liver cirrhosis1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Capital Medical University1 trial
- Shenzhen HighTide Biopharmaceutical Ltd.1 trial
- Tongji Hospital1 trial
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 trial
- Wan-Jin Chen1 trial
- and 1 more
Running trials
Recruiting
Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC
Recruiting
Recruiting
Recruiting
Active, not recruiting
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Liver cirrhosis1 recruiting
- Mild cognitive impairment1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026